37.03
price up icon2.58%   0.93
after-market Handel nachbörslich: 37.03
loading
Schlusskurs vom Vortag:
$36.10
Offen:
$35.98
24-Stunden-Volumen:
234.07K
Relative Volume:
0.48
Marktkapitalisierung:
$754.30M
Einnahmen:
$1.77M
Nettoeinkommen (Verlust:
$-123.74M
KGV:
-4.0382
EPS:
-9.17
Netto-Cashflow:
$-95.21M
1W Leistung:
-1.73%
1M Leistung:
+1.70%
6M Leistung:
-53.39%
1J Leistung:
-18.09%
1-Tages-Spanne:
Value
$35.21
$37.55
1-Wochen-Bereich:
Value
$35.21
$38.86
52-Wochen-Spanne:
Value
$26.70
$91.83

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Name
Firmenname
Praxis Precision Medicines Inc
Name
Telefon
617-300-8460
Name
Adresse
99 HIGH STREET, 30TH FLOOR, BOSTON
Name
Mitarbeiter
82
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
PRAX's Discussions on Twitter

Vergleichen Sie PRAX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PRAX
Praxis Precision Medicines Inc
37.03 767.50M 1.77M -123.74M -95.21M -9.17
Biotechnology icon
ONC
Beigene Ltd Adr
240.41 25.57B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.10 111.79B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.30 39.90M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
591.85 65.28B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.93 6.31B 0 -153.72M -103.81M -2.00

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-07 Eingeleitet Chardan Capital Markets Buy
2025-03-03 Bestätigt H.C. Wainwright Buy
2025-02-11 Eingeleitet Deutsche Bank Buy
2024-08-05 Eingeleitet Oppenheimer Outperform
2024-06-24 Eingeleitet Needham Buy
2024-06-18 Eingeleitet Guggenheim Buy
2024-05-01 Eingeleitet Robert W. Baird Outperform
2023-09-19 Eingeleitet Truist Buy
2022-06-06 Herabstufung Wedbush Outperform → Neutral
2021-12-16 Eingeleitet H.C. Wainwright Buy
2021-08-26 Eingeleitet BofA Securities Buy
2021-04-26 Eingeleitet William Blair Outperform
2020-11-11 Eingeleitet Wedbush Outperform
2020-11-10 Eingeleitet Cowen Outperform
2020-11-10 Eingeleitet Evercore ISI Outperform
2020-11-10 Eingeleitet Piper Sandler Overweight
Alle ansehen

Praxis Precision Medicines Inc Aktie (PRAX) Neueste Nachrichten

pulisher
May 26, 2025

(PRAX) Trading Report - news.stocktradersdaily.com

May 26, 2025
pulisher
May 26, 2025

Deutsche Bank AG Buys 5,009 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

May 26, 2025
pulisher
May 21, 2025

Praxis Precision Medicines to Participate in Upcoming Conferences - GlobeNewswire

May 21, 2025
pulisher
May 20, 2025

Praxis Precision Medicines to Participate in Upcoming Conferences | PRAX Stock News - GuruFocus

May 20, 2025
pulisher
May 18, 2025

What is Chardan Capital’s Forecast for PRAX FY2025 Earnings? - Defense World

May 18, 2025
pulisher
May 17, 2025

Dimensional Fund Advisors LP Decreases Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

May 17, 2025
pulisher
May 17, 2025

Northern Trust Corp Raises Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

May 17, 2025
pulisher
May 16, 2025

(PRAX) Investment Report - news.stocktradersdaily.com

May 16, 2025
pulisher
May 12, 2025

Piper Sandler maintains Praxis stock at $270 target, bullish stance By Investing.com - Investing.com India

May 12, 2025
pulisher
May 10, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Research Coverage Started at Chardan Capital - Defense World

May 10, 2025
pulisher
May 10, 2025

Praxis Precision Medicines (PRAX) to Release Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

May 09, 2025
pulisher
May 08, 2025

Analytical Lens: Exploring Praxis Precision Medicines Inc (PRAX)’s Financial Story Through Ratios - DWinneX

May 08, 2025
pulisher
May 08, 2025

3,008 Shares in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Bought by Envestnet Asset Management Inc. - Defense World

May 08, 2025
pulisher
May 08, 2025

Wedbush Has Positive Outlook for PRAX Q2 Earnings - Defense World

May 08, 2025
pulisher
May 08, 2025

This Waste Connections Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - NewsBreak: Local News & Alerts

May 08, 2025
pulisher
May 08, 2025

HC Wainwright Issues Negative Forecast for PRAX Earnings - Defense World

May 08, 2025
pulisher
May 07, 2025

Praxis Precision Medicines 'A Diversified Player In Epilepsy Market,' Analyst Sees Over 100% Stock Upside - Benzinga

May 07, 2025
pulisher
May 07, 2025

Chardan Capital Initiates Coverage of Praxis Precision Medicines (PRAX) with Buy Recommendation - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Chardan Capital Initiates Coverage on PRAX with a Buy Rating | PRAX Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Chardan Initiates Praxis Precision Medicines at Buy With $80 Price Target - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

Chardan Initiates Coverage on Praxis Precision (PRAX) with Buy Rating | PRAX Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Analysts Issue Forecasts for PRAX Q4 Earnings - Defense World

May 07, 2025
pulisher
May 07, 2025

HC Wainwright Has Bearish Forecast for PRAX FY2029 Earnings - Defense World

May 07, 2025
pulisher
May 06, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Given New $28.00 Price Target at Wedbush - Defense World

May 06, 2025
pulisher
May 06, 2025

Analysts Offer Insights on Healthcare Companies: Cerus (CERS), Stryker (SYK) and Praxis Precision Medicines (PRAX) - The Globe and Mail

May 06, 2025
pulisher
May 06, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Receives “Buy” Rating from Needham & Company LLC - Defense World

May 06, 2025
pulisher
May 06, 2025

Praxis Precision Medicines Highlights DEE Clinical Program Updates at Virtual Investor Event - GlobeNewswire

May 06, 2025
pulisher
May 06, 2025

Praxis Precision Medicines: Advancements and Financial Outlook - TipRanks

May 06, 2025
pulisher
May 05, 2025

Wedbush Adjusts Price Target for Praxis Precision Medicine (PRAX - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Wedbush Adjusts Price Target for Praxis Precision Medicine (PRAX) | PRAX Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

PRAX Stock Target Increased by Baird Amid Positive Epilepsy Drug Outlook | PRAX Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Wedbush Lifts Price Target on Praxis Precision Medicines to $28 From $26, Keeps Underperform Rating - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

PRAX Unveils Progress in DEE Clinical Programs | PRAX Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Clinical Trial Success: Praxis's DEE Drug Cuts Seizures by 90%, Eyes $3B Market Opportunity - Stock Titan

May 05, 2025
pulisher
May 05, 2025

Praxis Precision Medicine (PRAX): Buy Rating Reiterated by Needham | PRAX Stock News - GuruFocus

May 05, 2025
pulisher
May 04, 2025

Praxis Precision Medicines First Quarter 2025 Earnings: US$3.29 loss per share (vs US$2.85 loss in 1Q 2024) - Yahoo

May 04, 2025
pulisher
May 02, 2025

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | PRAX Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines Awards 3,688 Restricted Stock Units to 5 New Non-Executive Hires - Stock Titan

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines Provides Corporate Update and Reports - GuruFocus

May 02, 2025
pulisher
May 02, 2025

PRAX Revenue Falls Short as Company Focuses on Epilepsy Portfoli - GuruFocus

May 02, 2025
pulisher
May 02, 2025

PRAX Revenue Falls Short as Company Focuses on Epilepsy Portfolio | PRAX Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines, Inc. SEC 10-Q Report - TradingView

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines Reports Significant Progress and Upcoming Milestones in Epilepsy Portfolio - Nasdaq

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewswire

May 02, 2025
pulisher
May 02, 2025

Wells Fargo & Company MN Boosts Stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

May 02, 2025
pulisher
May 01, 2025

Assessing Praxis Precision Medicine: Insights From 8 Financial Analysts - Benzinga

May 01, 2025
pulisher
May 01, 2025

PRAX: HC Wainwright Reiterates Buy Rating and $105 Price Target | PRAX Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Praxis Precision Medicines Inc (PRAX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX

May 01, 2025

Finanzdaten der Praxis Precision Medicines Inc-Aktie (PRAX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.05
price down icon 8.70%
$30.28
price down icon 2.39%
$576.24
price down icon 0.61%
$285.56
price down icon 1.56%
$4.35
price up icon 1.64%
$73.93
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):